A novel surgical approach for the management of giant invasive prolactinoma compressing the brainstem
Summary Prolactinomas constitute the largest subsection of all secretory pituitary adenomas. Most are microprolactinomas and are satisfactorily treated by medical management alone. Giant prolactinomas, measuring more than 4 cm in diameter, are rare and usually occur more commonly in men. Macroprolat...
Gespeichert in:
Veröffentlicht in: | Endocrinology, diabetes & metabolism case reports diabetes & metabolism case reports, 2016-01, Vol.2016, p.150103-150103 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 150103 |
---|---|
container_issue | |
container_start_page | 150103 |
container_title | Endocrinology, diabetes & metabolism case reports |
container_volume | 2016 |
creator | Margari, Niki Pollock, Jonathan Stojanovic, Nemanja |
description | Summary Prolactinomas constitute the largest subsection of all secretory pituitary adenomas. Most are microprolactinomas and are satisfactorily treated by medical management alone. Giant prolactinomas, measuring more than 4 cm in diameter, are rare and usually occur more commonly in men. Macroprolatinomas tend to present with symptoms of mass effect rather than those of hyperprolactinaemia. Dopamine agonists (DA) are the treatment of choice for all prolactinomas. Surgery is usually reserved for DA resistance or if vision is threatened by the mass effects of the tumour. We describe the case of a 52 year-old woman with a giant invasive prolactinoma who required multiple surgical procedures as well as medical management with DA. One of the surgical interventions required a posterior approach via the trans cranial sub occipital transtentorial approach, a surgical technique that has not been previously described in the medical literature for this indication. The giant prolactinoma was reduced significantly with the above approach and patient symptoms from the compressing effects of the tumour were resolved. This case highlights the importance of a multidisciplinary approach to the management of such patients who present with florid neurological sequelae secondary to pressure effects. Although this presentation is uncommon, surgery via a sub occipital transtentorial approach may be considered the treatment of choice in suitable patients with giant invasive prolactinomas compressing the brainstem. Learning points Giant prolactinomas present with symptoms of mass effect or those of hyperprolactinaemia. Interpretation of the pituitary profile is crucial to guide further investigations and management. Treatment of giant invasive prolactinomas may involve a combination of medical management and multiple surgical interventions. Treatment with DA may cause pituitary haemorrhage or infarction in patients with these tumours. A sub occipital transtetorial approach may be considered the treatment of choice in invasive prolactinomas compressing the brainstem. Multidisciplinary approach of such patients is fundamental for a better outcome. |
doi_str_mv | 10.1530/EDM-15-0103 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4700283</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1754521625</sourcerecordid><originalsourceid>FETCH-LOGICAL-b311t-fea6bd37bcc7cc8db591ed638fb992bd36f8d18fb45c6e7c43e9183bb64f90143</originalsourceid><addsrcrecordid>eNp9kc9L5DAUx8Oysg7qae-S48JSTZombS8Lw_gTRrzoOSTpSyfSJt2kM-B_b3RccS-e8g3v877vC1-EflJyRjkj55cXdwXlBaGEfUOLkvCyILxm3z_pQ3SS0hMhmeFMNOwHOixFzapKNAsES-zDDgactrF3Rg1YTVMMymywDRHPG8Cj8qqHEfyMg8W9U1k4v1PJ7QBndlBmdj6MCpswThFScr5_29RROZ9mGI_RgVVDgpP39wg9Xl0-rG6K9f317Wq5LjSjdC4sKKE7VmtjamOaTvOWQidYY3XblnkibNPR_Ku4EVCbikFLG6a1qGxLaMWO0J-977TVI3QmZ45qkFN0o4rPMign_594t5F92MmqJqRsWDb49W4Qw98tpFmOLhkYBuUhbJOkNa94SUXJM_p7j5oYUopgP85QIl-7kbmbLORrN5k-_Zzsg_3XRAboHtAuJONyPmdzH1-avgB4mZz6</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1754521625</pqid></control><display><type>article</type><title>A novel surgical approach for the management of giant invasive prolactinoma compressing the brainstem</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Margari, Niki ; Pollock, Jonathan ; Stojanovic, Nemanja</creator><creatorcontrib>Margari, Niki ; Pollock, Jonathan ; Stojanovic, Nemanja</creatorcontrib><description>Summary Prolactinomas constitute the largest subsection of all secretory pituitary adenomas. Most are microprolactinomas and are satisfactorily treated by medical management alone. Giant prolactinomas, measuring more than 4 cm in diameter, are rare and usually occur more commonly in men. Macroprolatinomas tend to present with symptoms of mass effect rather than those of hyperprolactinaemia. Dopamine agonists (DA) are the treatment of choice for all prolactinomas. Surgery is usually reserved for DA resistance or if vision is threatened by the mass effects of the tumour. We describe the case of a 52 year-old woman with a giant invasive prolactinoma who required multiple surgical procedures as well as medical management with DA. One of the surgical interventions required a posterior approach via the trans cranial sub occipital transtentorial approach, a surgical technique that has not been previously described in the medical literature for this indication. The giant prolactinoma was reduced significantly with the above approach and patient symptoms from the compressing effects of the tumour were resolved. This case highlights the importance of a multidisciplinary approach to the management of such patients who present with florid neurological sequelae secondary to pressure effects. Although this presentation is uncommon, surgery via a sub occipital transtentorial approach may be considered the treatment of choice in suitable patients with giant invasive prolactinomas compressing the brainstem. Learning points Giant prolactinomas present with symptoms of mass effect or those of hyperprolactinaemia. Interpretation of the pituitary profile is crucial to guide further investigations and management. Treatment of giant invasive prolactinomas may involve a combination of medical management and multiple surgical interventions. Treatment with DA may cause pituitary haemorrhage or infarction in patients with these tumours. A sub occipital transtetorial approach may be considered the treatment of choice in invasive prolactinomas compressing the brainstem. Multidisciplinary approach of such patients is fundamental for a better outcome.</description><identifier>ISSN: 2052-0573</identifier><identifier>EISSN: 2052-0573</identifier><identifier>DOI: 10.1530/EDM-15-0103</identifier><identifier>PMID: 26734468</identifier><language>eng</language><publisher>England: Bioscientifica Ltd</publisher><subject>Adult ; Cabergoline ; CT scan ; Dopamine agonists ; Dyspnoea ; Female ; FT4 ; Glucocorticoids ; Hydrocortisone ; Hyperprolactinaemia ; Hypersalivation ; Hypopituitarism ; Hypothyroidism ; Macroprolactinoma ; MRI ; Novel Treatment ; Oncology ; Ophthalmoplegia ; Pituitary ; Pituitary adenoma ; Pituitary function ; Prolactin ; Prolactinoma ; Proptosis ; Resection of tumour ; Slurred speech ; Tetraparesis ; Thyroid function ; Transtentorial surgery ; TSH ; United Kingdom ; Visual impairment ; White</subject><ispartof>Endocrinology, diabetes & metabolism case reports, 2016-01, Vol.2016, p.150103-150103</ispartof><rights>This is an Open Access article distributed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.</rights><rights>2016 The authors 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-b311t-fea6bd37bcc7cc8db591ed638fb992bd36f8d18fb45c6e7c43e9183bb64f90143</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700283/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700283/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26734468$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Margari, Niki</creatorcontrib><creatorcontrib>Pollock, Jonathan</creatorcontrib><creatorcontrib>Stojanovic, Nemanja</creatorcontrib><title>A novel surgical approach for the management of giant invasive prolactinoma compressing the brainstem</title><title>Endocrinology, diabetes & metabolism case reports</title><addtitle>Endocrinol Diabetes Metab Case Rep</addtitle><description>Summary Prolactinomas constitute the largest subsection of all secretory pituitary adenomas. Most are microprolactinomas and are satisfactorily treated by medical management alone. Giant prolactinomas, measuring more than 4 cm in diameter, are rare and usually occur more commonly in men. Macroprolatinomas tend to present with symptoms of mass effect rather than those of hyperprolactinaemia. Dopamine agonists (DA) are the treatment of choice for all prolactinomas. Surgery is usually reserved for DA resistance or if vision is threatened by the mass effects of the tumour. We describe the case of a 52 year-old woman with a giant invasive prolactinoma who required multiple surgical procedures as well as medical management with DA. One of the surgical interventions required a posterior approach via the trans cranial sub occipital transtentorial approach, a surgical technique that has not been previously described in the medical literature for this indication. The giant prolactinoma was reduced significantly with the above approach and patient symptoms from the compressing effects of the tumour were resolved. This case highlights the importance of a multidisciplinary approach to the management of such patients who present with florid neurological sequelae secondary to pressure effects. Although this presentation is uncommon, surgery via a sub occipital transtentorial approach may be considered the treatment of choice in suitable patients with giant invasive prolactinomas compressing the brainstem. Learning points Giant prolactinomas present with symptoms of mass effect or those of hyperprolactinaemia. Interpretation of the pituitary profile is crucial to guide further investigations and management. Treatment of giant invasive prolactinomas may involve a combination of medical management and multiple surgical interventions. Treatment with DA may cause pituitary haemorrhage or infarction in patients with these tumours. A sub occipital transtetorial approach may be considered the treatment of choice in invasive prolactinomas compressing the brainstem. Multidisciplinary approach of such patients is fundamental for a better outcome.</description><subject>Adult</subject><subject>Cabergoline</subject><subject>CT scan</subject><subject>Dopamine agonists</subject><subject>Dyspnoea</subject><subject>Female</subject><subject>FT4</subject><subject>Glucocorticoids</subject><subject>Hydrocortisone</subject><subject>Hyperprolactinaemia</subject><subject>Hypersalivation</subject><subject>Hypopituitarism</subject><subject>Hypothyroidism</subject><subject>Macroprolactinoma</subject><subject>MRI</subject><subject>Novel Treatment</subject><subject>Oncology</subject><subject>Ophthalmoplegia</subject><subject>Pituitary</subject><subject>Pituitary adenoma</subject><subject>Pituitary function</subject><subject>Prolactin</subject><subject>Prolactinoma</subject><subject>Proptosis</subject><subject>Resection of tumour</subject><subject>Slurred speech</subject><subject>Tetraparesis</subject><subject>Thyroid function</subject><subject>Transtentorial surgery</subject><subject>TSH</subject><subject>United Kingdom</subject><subject>Visual impairment</subject><subject>White</subject><issn>2052-0573</issn><issn>2052-0573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNp9kc9L5DAUx8Oysg7qae-S48JSTZombS8Lw_gTRrzoOSTpSyfSJt2kM-B_b3RccS-e8g3v877vC1-EflJyRjkj55cXdwXlBaGEfUOLkvCyILxm3z_pQ3SS0hMhmeFMNOwHOixFzapKNAsES-zDDgactrF3Rg1YTVMMymywDRHPG8Cj8qqHEfyMg8W9U1k4v1PJ7QBndlBmdj6MCpswThFScr5_29RROZ9mGI_RgVVDgpP39wg9Xl0-rG6K9f317Wq5LjSjdC4sKKE7VmtjamOaTvOWQidYY3XblnkibNPR_Ku4EVCbikFLG6a1qGxLaMWO0J-977TVI3QmZ45qkFN0o4rPMign_594t5F92MmqJqRsWDb49W4Qw98tpFmOLhkYBuUhbJOkNa94SUXJM_p7j5oYUopgP85QIl-7kbmbLORrN5k-_Zzsg_3XRAboHtAuJONyPmdzH1-avgB4mZz6</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Margari, Niki</creator><creator>Pollock, Jonathan</creator><creator>Stojanovic, Nemanja</creator><general>Bioscientifica Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160101</creationdate><title>A novel surgical approach for the management of giant invasive prolactinoma compressing the brainstem</title><author>Margari, Niki ; Pollock, Jonathan ; Stojanovic, Nemanja</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b311t-fea6bd37bcc7cc8db591ed638fb992bd36f8d18fb45c6e7c43e9183bb64f90143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Cabergoline</topic><topic>CT scan</topic><topic>Dopamine agonists</topic><topic>Dyspnoea</topic><topic>Female</topic><topic>FT4</topic><topic>Glucocorticoids</topic><topic>Hydrocortisone</topic><topic>Hyperprolactinaemia</topic><topic>Hypersalivation</topic><topic>Hypopituitarism</topic><topic>Hypothyroidism</topic><topic>Macroprolactinoma</topic><topic>MRI</topic><topic>Novel Treatment</topic><topic>Oncology</topic><topic>Ophthalmoplegia</topic><topic>Pituitary</topic><topic>Pituitary adenoma</topic><topic>Pituitary function</topic><topic>Prolactin</topic><topic>Prolactinoma</topic><topic>Proptosis</topic><topic>Resection of tumour</topic><topic>Slurred speech</topic><topic>Tetraparesis</topic><topic>Thyroid function</topic><topic>Transtentorial surgery</topic><topic>TSH</topic><topic>United Kingdom</topic><topic>Visual impairment</topic><topic>White</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Margari, Niki</creatorcontrib><creatorcontrib>Pollock, Jonathan</creatorcontrib><creatorcontrib>Stojanovic, Nemanja</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Endocrinology, diabetes & metabolism case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Margari, Niki</au><au>Pollock, Jonathan</au><au>Stojanovic, Nemanja</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A novel surgical approach for the management of giant invasive prolactinoma compressing the brainstem</atitle><jtitle>Endocrinology, diabetes & metabolism case reports</jtitle><addtitle>Endocrinol Diabetes Metab Case Rep</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>2016</volume><spage>150103</spage><epage>150103</epage><pages>150103-150103</pages><issn>2052-0573</issn><eissn>2052-0573</eissn><abstract>Summary Prolactinomas constitute the largest subsection of all secretory pituitary adenomas. Most are microprolactinomas and are satisfactorily treated by medical management alone. Giant prolactinomas, measuring more than 4 cm in diameter, are rare and usually occur more commonly in men. Macroprolatinomas tend to present with symptoms of mass effect rather than those of hyperprolactinaemia. Dopamine agonists (DA) are the treatment of choice for all prolactinomas. Surgery is usually reserved for DA resistance or if vision is threatened by the mass effects of the tumour. We describe the case of a 52 year-old woman with a giant invasive prolactinoma who required multiple surgical procedures as well as medical management with DA. One of the surgical interventions required a posterior approach via the trans cranial sub occipital transtentorial approach, a surgical technique that has not been previously described in the medical literature for this indication. The giant prolactinoma was reduced significantly with the above approach and patient symptoms from the compressing effects of the tumour were resolved. This case highlights the importance of a multidisciplinary approach to the management of such patients who present with florid neurological sequelae secondary to pressure effects. Although this presentation is uncommon, surgery via a sub occipital transtentorial approach may be considered the treatment of choice in suitable patients with giant invasive prolactinomas compressing the brainstem. Learning points Giant prolactinomas present with symptoms of mass effect or those of hyperprolactinaemia. Interpretation of the pituitary profile is crucial to guide further investigations and management. Treatment of giant invasive prolactinomas may involve a combination of medical management and multiple surgical interventions. Treatment with DA may cause pituitary haemorrhage or infarction in patients with these tumours. A sub occipital transtetorial approach may be considered the treatment of choice in invasive prolactinomas compressing the brainstem. Multidisciplinary approach of such patients is fundamental for a better outcome.</abstract><cop>England</cop><pub>Bioscientifica Ltd</pub><pmid>26734468</pmid><doi>10.1530/EDM-15-0103</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2052-0573 |
ispartof | Endocrinology, diabetes & metabolism case reports, 2016-01, Vol.2016, p.150103-150103 |
issn | 2052-0573 2052-0573 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4700283 |
source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; PubMed Central Open Access |
subjects | Adult Cabergoline CT scan Dopamine agonists Dyspnoea Female FT4 Glucocorticoids Hydrocortisone Hyperprolactinaemia Hypersalivation Hypopituitarism Hypothyroidism Macroprolactinoma MRI Novel Treatment Oncology Ophthalmoplegia Pituitary Pituitary adenoma Pituitary function Prolactin Prolactinoma Proptosis Resection of tumour Slurred speech Tetraparesis Thyroid function Transtentorial surgery TSH United Kingdom Visual impairment White |
title | A novel surgical approach for the management of giant invasive prolactinoma compressing the brainstem |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T22%3A47%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20novel%20surgical%20approach%20for%20the%20management%20of%20giant%20invasive%20prolactinoma%20compressing%20the%20brainstem&rft.jtitle=Endocrinology,%20diabetes%20&%20metabolism%20case%20reports&rft.au=Margari,%20Niki&rft.date=2016-01-01&rft.volume=2016&rft.spage=150103&rft.epage=150103&rft.pages=150103-150103&rft.issn=2052-0573&rft.eissn=2052-0573&rft_id=info:doi/10.1530/EDM-15-0103&rft_dat=%3Cproquest_pubme%3E1754521625%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1754521625&rft_id=info:pmid/26734468&rfr_iscdi=true |